Skip to main content
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Clin Cancer Res. 2020 Jun 22;26(18):4852–4862. doi: 10.1158/1078-0432.CCR-20-0638

Figure 1. Coexisting cfDNA mutations in patients with MBC with cfDNA BRCA1/2 mutations.

Figure 1.

Blue depicts wild-type genes, yellow denotes known pathogenic mutations, and green signifies novel variants.